Literature DB >> 24018214

Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference?

Michel H E Hermans1.   

Abstract

Porcine xenografts and cryopreserved allografts are used for the management of partial thickness burns and both biological materials have strong advocates with regard to clinical performance, the possibility of disease transfer from donor to recipient and other clinical aspects. A literature analysis was performed in an attempt to investigate whether true (statistically significant) differences exist on clinical performance and on other determinants for use. Comparing the results of this study with a similar, previously published study performed on possible differences amongst different types of allograft in the management of partial thickness burns, both allografts and porcine xenograft seem to perform equally well clinically with regard to healing related outcomes. In addition, the risk of disease transfer, in real life, was shown to be minimal. Consequently, clinical aspects being equal, other aspects such as price and availability should be used to decide which material to use for the management of partial thickness burns.
Copyright © 2013 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Cost; Cryopreserved allograft; Disease transfer; Healing; Partial thickness burns; Porcine xenograft

Mesh:

Year:  2013        PMID: 24018214     DOI: 10.1016/j.burns.2013.08.020

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  19 in total

Review 1.  Novel pharmacotherapy for burn wounds: what are the advancements.

Authors:  Michael R Hamblin
Journal:  Expert Opin Pharmacother       Date:  2018-12-05       Impact factor: 3.889

Review 2.  Advanced therapies of skin injuries.

Authors:  Tina Maver; Uroš Maver; Karin Stana Kleinschek; Irena Mlinarič Raščan; Dragica Maja Smrke
Journal:  Wien Klin Wochenschr       Date:  2015-09-24       Impact factor: 1.704

3.  Clinical Impact of Cryopreservation on Split Thickness Skin Grafts in the Porcine Model.

Authors:  Paul W Holzer; Alexandre G Lellouch; Krysta Moulton; Laurence Zhu; Zhi Yang Ng; Bo Overschmidt; Amon-Ra Gama; Angelo A Leto Barone; Ivy Rosales; Rod Monroy; Curtis L Cetrulo
Journal:  J Burn Care Res       Date:  2020-02-19       Impact factor: 1.845

4.  Evaluation of genipin for stabilization of decellularized porcine cartilage.

Authors:  Steven Elder; Amanda Pinheiro; Christian Young; Preston Smith; Emily Wright
Journal:  J Orthop Res       Date:  2017-03-24       Impact factor: 3.494

5.  Xenotransplantation: Progress Along Paths Uncertain from Models to Application.

Authors:  Jeffrey L Platt; Marilia Cascalho; Jorge A Piedrahita
Journal:  ILAR J       Date:  2018-12-31

Review 6.  Skin xenotransplantation: Historical review and clinical potential.

Authors:  Takayuki Yamamoto; Hayato Iwase; Timothy W King; Hidetaka Hara; David K C Cooper
Journal:  Burns       Date:  2018-03-27       Impact factor: 2.744

Review 7.  Indeterminate-Depth Burn Injury-Exploring the Uncertainty.

Authors:  Aos S Karim; Katherine Shaum; Angela L F Gibson
Journal:  J Surg Res       Date:  2019-08-14       Impact factor: 2.192

Review 8.  Burn wound healing and treatment: review and advancements.

Authors:  Matthew P Rowan; Leopoldo C Cancio; Eric A Elster; David M Burmeister; Lloyd F Rose; Shanmugasundaram Natesan; Rodney K Chan; Robert J Christy; Kevin K Chung
Journal:  Crit Care       Date:  2015-06-12       Impact factor: 9.097

9.  Observation of viable alloskin vs xenoskin grafted onto subcutaneous tissue wounds after tangential excision in massive burns.

Authors:  Haibin Zuo; Guodong Song; Wen Shi; Jun Jia; Yonghu Zhang
Journal:  Burns Trauma       Date:  2016-05-27

10.  Monitoring wound healing of burn in rat model using human Wharton's jelly mesenchymal stem cells containing cGFP integrated by lentiviral vectors.

Authors:  Mohammad Reza Pourfath; Abbas Behzad-Behbahani; Seyedeh Sara Hashemi; Amin Derakhsahnfar; Mohammad Naser Taheri; Saeede Salehi
Journal:  Iran J Basic Med Sci       Date:  2018-01       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.